Dystrophic Epidermolysis Bullosa Research Assn Of America Inc
DEBRA of America consistently reports 0% officer compensation and maintains a stable financial position with recent surpluses.
EIN: 112519726 · Boulder, CO · Updated: 2026-03-28
Is Dystrophic Epidermolysis Bullosa Research Assn Of America Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Dystrophic Epidermolysis Bullosa Research Assn Of America Inc directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Dystrophic Epidermolysis Bullosa Research Assn Of America Inc
Dystrophic Epidermolysis Bullosa Research Assn Of America Inc (EIN: 112519726) is a nonprofit organization based in Boulder, CO. The organization reported total revenue of $3.4M and total assets of $1.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Dystrophic Epidermolysis Bullosa Research Assn Of America Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Dystrophic Epidermolysis Bullosa Research Assn Of America Inc is a mid-size nonprofit that has been operating for 44 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 10.6%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.6M |
| Total Expenses | $1.6M |
| Surplus / Deficit | +$1.0M |
| Total Assets | $1.9M |
| Total Liabilities | $199K |
| Net Assets | $1.7M |
| Operating Margin | 39.6% |
| Debt-to-Asset Ratio | 10.3% |
| Months of Reserves | 14.8 months |
Financial Health Grade: A
In 2023, Dystrophic Epidermolysis Bullosa Research Assn Of America Inc reported a surplus of $1.0M with revenue exceeding expenses, holds 14.8 months of operating reserves (strong position), has a debt-to-asset ratio of 10.3% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Dystrophic Epidermolysis Bullosa Research Assn Of America Inc's revenue has grown at a compound annual growth rate (CAGR) of 10.6%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -22.4% | -20.1% | -7.2% |
| 2022 | +202.5% | +17.7% | -5.7% |
| 2021 | -40.8% | +22.3% | -25.5% |
| 2020 | +20.1% | -6.7% | +23.7% |
| 2019 | -14.4% | -31.9% | +0.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1982 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Dystrophic Epidermolysis Bullosa Research Assn Of America Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, Dystrophic Epidermolysis Bullosa Research Assn Of America Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.0M, with revenue exceeding expenses.
- Debt-to-asset ratio: 10.3%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that no officers received compensation from the organization, which is highly unusual for an organization of this size with revenues often exceeding $1.5 million annually.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Dystrophic Epidermolysis Bullosa Research Assn Of America Inc's IRS 990 filings:
- Lack of detailed expense breakdown (program, admin, fundraising) in provided data prevents full efficiency analysis.
Strengths
The following positive indicators were identified for Dystrophic Epidermolysis Bullosa Research Assn Of America Inc:
- Consistent reporting of 0% officer compensation across all filings.
- Positive net income in recent years (e.g., $1,032,114 in 2023 and $1,387,934 in 2022).
- Healthy asset-to-liability ratio (e.g., 9.7:1 in 2023).
- Long history of IRS 990 filings, indicating transparency and compliance.
Frequently Asked Questions about Dystrophic Epidermolysis Bullosa Research Assn Of America Inc
Is Dystrophic Epidermolysis Bullosa Research Assn Of America Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Dystrophic Epidermolysis Bullosa Research Assn Of America Inc (EIN: 112519726) some concerns. Mission Score: 85/100. 1 red flag identified, 4 strengths noted.
How does Dystrophic Epidermolysis Bullosa Research Assn Of America Inc spend its money?
Dystrophic Epidermolysis Bullosa Research Assn Of America Inc directs 75% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Dystrophic Epidermolysis Bullosa Research Assn Of America Inc tax-deductible?
Dystrophic Epidermolysis Bullosa Research Assn Of America Inc is registered as a tax-exempt nonprofit (EIN: 112519726). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Is DEBRA of America a good charity?
Based on the provided data, DEBRA of America appears to be a financially stable organization with a strong commitment to its mission, evidenced by consistent surpluses in recent years and 0% officer compensation. However, a full assessment would require detailed expense breakdowns.
How has DEBRA of America's revenue trended?
Revenue has fluctuated, with a significant peak of $3,356,992 in 2022, followed by $2,604,819 in 2023. This indicates a capacity for substantial fundraising, though it's not consistently increasing year-over-year.
What is the organization's asset-to-liability ratio?
In 2023, assets were $1,940,472 and liabilities were $199,374, resulting in a healthy asset-to-liability ratio of approximately 9.7:1, indicating strong financial solvency.
Is the organization financially stable?
Yes, the organization appears financially stable. It has consistently maintained positive net assets, and recent years (2022, 2023) show revenues significantly exceeding expenses, leading to surpluses.
Filing History
IRS 990 filing history for Dystrophic Epidermolysis Bullosa Research Assn Of America Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Dystrophic Epidermolysis Bullosa Research Assn Of America Inc's revenue has grown by 236.6%, moving from $774K to $2.6M. Total assets increased by 108.3% over the same period, from $931K to $1.9M. Total functional expenses rose by 125.8%, from $696K to $1.6M. In its most recent filing year (2023), Dystrophic Epidermolysis Bullosa Research Assn Of America Inc reported a surplus of $1.0M, with revenue exceeding expenses. The organization holds $199K in liabilities against $1.9M in assets (debt-to-asset ratio: 10.3%), resulting in net assets of $1.7M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.6M | $1.6M | $1.9M | $199K | — | View 990 |
| 2022 | $3.4M | $2.0M | $2.1M | $294K | — | View 990 |
| 2021 | $1.1M | $1.7M | $2.2M | $359K | — | View 990 |
| 2020 | $1.9M | $1.4M | $3.0M | $322K | — | View 990 |
| 2019 | $1.6M | $1.5M | $2.4M | $312K | — | View 990 |
| 2018 | $1.8M | $2.2M | $2.4M | $280K | — | View 990 |
| 2017 | $1.4M | $1.4M | $2.9M | $166K | — | View 990 |
| 2016 | $1.6M | $1.6M | $2.8M | $59K | — | View 990 |
| 2015 | $1.6M | $1.2M | $2.7M | $38K | — | View 990 |
| 2014 | $1.6M | $1.3M | $1.7M | $62K | — | View 990 |
| 2013 | $1.4M | $992K | $1.5M | $128K | — | View 990 |
| 2012 | $1.2M | $1.1M | $1.2M | $171K | — | View 990 |
| 2011 | $774K | $696K | $931K | $20K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.6M, expenses of $1.6M, and assets of $1.9M (revenue -22.4% year-over-year).
- 2022: Revenue of $3.4M, expenses of $2.0M, and assets of $2.1M (revenue +202.5% year-over-year).
- 2021: Revenue of $1.1M, expenses of $1.7M, and assets of $2.2M (revenue -40.8% year-over-year).
- 2020: Revenue of $1.9M, expenses of $1.4M, and assets of $3.0M (revenue +20.1% year-over-year).
- 2019: Revenue of $1.6M, expenses of $1.5M, and assets of $2.4M (revenue -14.4% year-over-year).
- 2018: Revenue of $1.8M, expenses of $2.2M, and assets of $2.4M (revenue +33.2% year-over-year).
- 2017: Revenue of $1.4M, expenses of $1.4M, and assets of $2.9M (revenue -14.8% year-over-year).
- 2016: Revenue of $1.6M, expenses of $1.6M, and assets of $2.8M (revenue +1.8% year-over-year).
- 2015: Revenue of $1.6M, expenses of $1.2M, and assets of $2.7M (revenue +1.7% year-over-year).
- 2014: Revenue of $1.6M, expenses of $1.3M, and assets of $1.7M (revenue +11.3% year-over-year).
- 2013: Revenue of $1.4M, expenses of $992K, and assets of $1.5M (revenue +19.7% year-over-year).
- 2012: Revenue of $1.2M, expenses of $1.1M, and assets of $1.2M (revenue +50.7% year-over-year).
- 2011: Revenue of $774K, expenses of $696K, and assets of $931K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Dystrophic Epidermolysis Bullosa Research Assn Of America Inc:
Data Sources and Methodology
This transparency report for Dystrophic Epidermolysis Bullosa Research Assn Of America Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.